mcph1 mimetic peptides (Mimetics)
90
Structured Review
Mimetics
mcph1 mimetic peptides
Mcph1 Mimetic Peptides, supplied by Mimetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcph1+mimetic+peptides/mcph1+mimetic+peptides/pm40099538-215-5-4
Average 90 stars, based on 1 article reviews
Mcph1 Mimetic Peptides, supplied by Mimetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcph1+mimetic+peptides/mcph1+mimetic+peptides/pm40099538-215-5-4
Average 90 stars, based on 1 article reviews
mcph1 mimetic peptides - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Labeling:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. Generated:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. Phospho-proteomics:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. Sequencing:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. In Silico:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. Derivative Assay:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. Binding Assay:Article Title: P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Article Snippet: Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐ stage detection and recurrence impacting survival.. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes.. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. |